Intuitive Surgical (NASDAQ:ISRG) stock is getting a boost on Friday as investors celebrate approval of da Vinci 5 by the Food and Drug Administration (FDA). Da Vinci 5 is the next generation of Intuitive Surgical’s multiport robotic system that has been used in more than 7 million procedures. The newest version brings with it increased performance, an enhanced 3D imaging system and new Force Feedback technology. Myriam J. Curet, M.D., Chief Medical Officer of Intuitive Surgical, said the following about the ...